We are live on
!
Find out more
CCM
Copernicus Capital Management Portfolio holdings
AUM
$8.26M
1-Year Est. Return
37.91%
This Fund
S&P 500
This Quarter
Est. Return
+14.67%
1 Year Est. Return
+37.91%
3 Year Est. Return
+125.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$31.3M
(-23%)
Cap. Flow
-$44.2M
Cap. Flow
% of AUM
-41.49%
Top 10 Holdings %
Top 10 Hldgs %
82.75%
Holding
23
New
4
Increased
3
Reduced
10
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$4.03M |
| 2 |
DaVita
DVA
|
+$2.75M |
| 3 |
Elanco Animal Health
ELAN
|
+$1.79M |
| 4 |
CareDx
CDNA
|
+$1.22M |
| 5 |
FOLD
Amicus Therapeutics
FOLD
|
+$1.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$10.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.15M |
| 3 |
HOLX
Hologic
HOLX
|
+$6.74M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$6.43M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
+$4.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
DaVita
DVA
$15.2B
| $12.6M | 11.86% |
176,403
+38,907
| +28% | +$2.75M |
|
2
Intuitive Surgical
ISRG
$121B
| $12.6M | 11.79% |
65,643
-6,576
| -9% | -$1.17M |
|
3
Stryker
SYK
$126B
| $12.4M | 11.62% |
69,652
-557
| -0.8% | -$95.1K |
|
4
Vertex Pharmaceuticals
VRTX
$122B
| $12.1M | 11.39% |
62,907
-3,533
| -5% | -$629K |
|
5
CVS Health
CVS
$138B
| $11M | 10.35% |
140,009
+4,414
| +3% | +$316K |
|
|
NUVA
6
DELISTED
NuVasive, Inc.
NUVA
| $6.19M | 5.81% |
87,205
-701
| -0.8% | -$44.6K |
|
7
Edwards Lifesciences
EW
$49.6B
| $5.67M | 5.32% |
97,632
-76,368
| -44% | -$3.74M |
|
|
FOLD
8
DELISTED
Amicus Therapeutics
FOLD
| $5.54M | 5.21% |
458,630
+85,832
| +23% | +$1.2M |
|
9
Zoetis
ZTS
$31.5B
| $5.08M | 4.77% |
55,460
-445
| -0.8% | -$39.5K |
|
|
10
Thermo Fisher Scientific
TMO
$208B
| $4.93M | 4.63% |
20,206
-35,439
| -64% | -$8.15M |
|
11
Henry Schein
HSIC
$9.73B
| $4.64M | 4.36% |
69,568
-557
| -0.8% | -$34.7K |
|
|
PDCO
12
DELISTED
Patterson Companies, Inc.
PDCO
| $4.16M | 3.9% |
+170,000
| New | +$4.03M |
|
|
13
Illumina
ILMN
$29.1B
| $3.6M | 3.38% |
10,076
-32,199
| -76% | -$10.3M |
|
|
14
CareDx
CDNA
$1.93B
| $1.88M | 1.76% |
+65,000
| New | +$1.22M |
|
|
15
Elanco Animal Health
ELAN
$12.3B
| $1.78M | 1.67% |
+51,000
| New | +$1.79M |
|
16
Heron Therapeutics
HRTX
$86.9M
| $1.35M | 1.27% |
42,822
-101,560
| -70% | -$3.78M |
|
|
FOLD
17
CALL
DELISTED
Amicus Therapeutics
FOLD
| $967K | 0.91% |
+80,000
| New | +$1.12M |
|
|
HOLX
18
DELISTED
Hologic
HOLX
| – | – |
-169,511
| Closed | -$6.74M |
|
19
Humana
HUM
$47.1B
| – | – |
-10,000
| Closed | -$2.98M |
|
20
Integra LifeSciences
IART
$1.48B
| – | – |
-63,000
| Closed | -$4.06M |
|
21
Molina Healthcare
MOH
$10.1B
| – | – |
-36,737
| Closed | -$3.6M |
|
|
CLVS
22
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-141,345
| Closed | -$6.43M |
|
|
ARRY
23
DELISTED
Array Biopharma Inc
ARRY
| – | – |
-286,797
| Closed | -$4.81M |
|
Similar funds
AAM
IR
YEPV
LC
MA
IFC
PVMCV
ARTA
Copernicus Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Copernicus Capital Management held 23 positions worth $107M, down 23% from $138M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Copernicus Capital Management withdrew a net $44.2M in Q3 2018, closing 6 positions and reducing 10 holdings. Its most notable exit was Hologic, an estimated $6.74M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.
Against the trend, Copernicus Capital Management opened a new position in Patterson Companies, Inc. worth $4.16M.
- Copernicus Capital Management's largest Q3 2018 buy was Patterson Companies, Inc.: 170,000 shares worth $4.16M.
- Copernicus Capital Management added most to DaVita in Q3 2018, an estimated $2.75M increase.
- Copernicus Capital Management's biggest Q3 2018 reduction was Illumina, cutting an estimated $10.3M.
- Copernicus Capital Management fully exited Hologic in Q3 2018, selling an estimated $6.74M.
- Copernicus Capital Management's ten largest holdings make up 83% of its $107M portfolio in Q3 2018.
- Copernicus Capital Management opened 4 new positions and closed 6 in Q3 2018.
- Copernicus Capital Management's portfolio value fell 23% quarter-over-quarter to $107M.
Based on Copernicus Capital Management's 13F filing for Q3 2018, filed 7 Nov 2018.